1-4 of 4
Carlos Fernández-Martos
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

An Exosome-Based Liquid Biopsy Predicts Depth of Response and Survival Outcomes to Cetuximab and Panitumumab in Metastatic Colorectal Cancer: The EXONERATE Study

Available to Purchase
Caiming Xu, Alessandro Mannucci, Francis Esposito, Helena Oliveres, Vicente Alonso-Orduña, Alfonso Yubero, Carlos Fernández-Martos, Antonieta Salud, Javier Gallego, Marta Martín-Richard, Julen Fernández-Plana, Mónica Guillot, Jorge Aparicio, Marwan Fakih, Scott Kopetz, Jaime Feliu, Joan Maurel, Ajay Goel
Journal: Clinical Cancer Research
Clin Cancer Res (2025) 31 (6): 1002–1015.
https://doi.org/10.1158/1078-0432.CCR-24-1934
Published: 17 March 2025
View articletitled, An Exosome-Based Liquid Biopsy Predicts Depth of Response and Survival Outcomes to Cetuximab and Panitumumab in Metastatic Colorectal Cancer: The EXONERATE Study
Open the PDF for An Exosome-Based Liquid Biopsy Predicts Depth of Response and Survival Outcomes to Cetuximab and Panitumumab in Metastatic Colorectal Cancer: The EXONERATE Study in another window
Includes: Supplementary data
Journal Articles

A Phase Ib Study of the DNA-PK Inhibitor Peposertib Combined with Neoadjuvant Chemoradiation in Patients with Locally Advanced Rectal Cancer

Open Access
Paul B. Romesser, Jaume Capdevila, Rocio Garcia-Carbonero, Tony Philip, Carlos Fernandez Martos, Richard Tuli, Almudena Rodriguez-Gutierrez, Mirjam Kuipers, Andreas Becker, Anna Coenen-Stass, Barbara Sarholz, Xiaoli You, Eric D. Miller
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (4): 695–702.
https://doi.org/10.1158/1078-0432.CCR-23-1129
Published: 16 February 2024
View articletitled, A Phase Ib Study of the DNA-PK Inhibitor Peposertib Combined with Neoadjuvant Chemoradiation in Patients with Locally Advanced Rectal Cancer
Open the PDF for A Phase Ib Study of the DNA-PK Inhibitor Peposertib Combined with Neoadjuvant Chemoradiation in Patients with Locally Advanced Rectal Cancer in another window
Includes: Supplementary data
Journal Articles

Clinical Impact of Presurgery Circulating Tumor DNA after Total Neoadjuvant Treatment in Locally Advanced Rectal Cancer: A Biomarker Study from the GEMCAD 1402 Trial

Available to Purchase
Joana Vidal, David Casadevall, Beatriz Bellosillo, Carles Pericay, Rocio Garcia-Carbonero, Ferran Losa, Laia Layos, Vicente Alonso, Jaume Capdevila, Javier Gallego, Ruth Vera, Antonieta Salud, Marta Martin-Richard, Miguel Nogué, Elena Cillán, Joan Maurel, Iris Faull, Victoria Raymond, Carlos Fernández-Martos, Clara Montagut
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (10): 2890–2898.
https://doi.org/10.1158/1078-0432.CCR-20-4769
Published: 15 May 2021
View articletitled, Clinical Impact of Presurgery Circulating Tumor DNA after Total Neoadjuvant Treatment in Locally Advanced Rectal Cancer: A Biomarker Study from the GEMCAD 1402 Trial
Open the PDF for Clinical Impact of Presurgery Circulating Tumor DNA after Total Neoadjuvant Treatment in Locally Advanced Rectal Cancer: A Biomarker Study from the GEMCAD 1402 Trial in another window
Includes: Supplementary data
Journal Articles

A Combined Strategy of SAGE and Quantitative PCR Provides a 13-Gene Signature that Predicts Preoperative Chemoradiotherapy Response and Outcome in Rectal Cancer

Free
Enrique Casado, Victor Moreno García, Jose Javier Sánchez, Montserrat Blanco, Joan Maurel, Jaime Feliu, Carlos Fernández-Martos, Javier de Castro, Beatriz Castelo, Cristóbal Belda-Iniesta, María Sereno, Benito Sánchez-Llamas, Emilio Burgos, Miguel Ángel García-Cabezas, Noemí Manceñido, Rosa Miquel, Damián García-Olmo, Manuel González-Barón, Paloma Cejas
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (12): 4145–4154.
https://doi.org/10.1158/1078-0432.CCR-10-2257
Published: 15 June 2011
View articletitled, A Combined Strategy of SAGE and Quantitative PCR Provides a 13-Gene Signature that Predicts Preoperative Chemoradiotherapy Response and Outcome in Rectal Cancer
Open the PDF for A Combined Strategy of SAGE and Quantitative PCR Provides a 13-Gene Signature that Predicts Preoperative Chemoradiotherapy Response and Outcome in Rectal Cancer in another window
Includes: Supplementary data